Measurement properties of the MDS-NMS Non-motor Fluctuations Subscale
Objective: This study aims at describing the measurement properties of the Non-motor Fluctuations (NMFs) subscale of the Movement Disorders Society Non-Motor Rating Scale (MDS-NMS) according…Opicapone improves motor and non-motor wearing off symptoms in Parkinson’s disease: an observational real-world study
Objective: To assess the impact of opicapone - a third generation COMT Inhibitor - on motor and non-motor wearing off symptoms in patients suffering from…Demographic Influences on Wearing Off Symptoms in Parkinson’s Disease
Objective: To examine differences in wearing off symptoms in Parkinson’s Disease (PD) according to gender, age, and age at PD diagnosis. Background: Off symptoms in…Exploring the relationship between motor and non-motor fluctuations in Parkinson’s disease: patient’s perspective, clinician’ s assessment and objective measures from a wearable device
Objective: We aimed: 1) To evaluate the relationship between motor (MF) and non-motor (NMF) fluctuations in Parkinson’s disease measured with patient’s self-assessment, clinician’s evaluationand objective measurement using a wearable…Polyneuropathy in patients with continuous levodopa/carbidopa intestinal gel (LCIG) infusion
Objective: To assess frequency of polyneuropathy in patients with LCIG and the usefulness of routine nerve conduction studies follow-up Background: Continuous levodopa infusion is an…Do non-motor fluctuations temporarily match ON/OFF motor condition?
Objective: The aim of this study was to explore the relation between non-motor neuropsychological fluctuations, identified with the Neuropsychiatric Fluctuation Scale (NFS), and motor fluctuations…Absence of wearing-off in Parkinson’s disease patients with treatment beyond 10 years
Objective: This study aims to explore the determinants for absence of wearing-off in patients with Parkinson’s disease (PD) based on a large cohort of Chinese…Cardiac sympathetic denervation can predict the wearing-off phenomenon in patients with Parkinson’s disease
Objective: To investigate whether cardiac sympathetic denervation increases the risk of the early wearing-off phenomenon in Parkinson's disease (PD). Background: Recent studies have suggested that…Efficacy of CVT-301 (levodopa inhalation powder) for treatment of OFF periods in Parkinson’s disease
Objective: Post-hoc analysis of subjects with Parkinson’s disease (PD) achieving > 30% reduction in UPDRS motor score (UPDRSIII) from pre- to post-dose over the first…Safinamide and Rasagiline effect on motor fluctuation, sleep quality and daytime sleepiness in Parkinson’s Disease: A validated questionnaires study
Objective: This is an observational study aimed at evaluating the effect of Safinamide and Rasagiline on motor fluctuations, subjective sleep and daytime sleepiness in Parkinson’s…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 26
- Next Page »